Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090599855> ?p ?o ?g. }
- W3090599855 endingPage "1284" @default.
- W3090599855 startingPage "1278" @default.
- W3090599855 abstract "Background No long-term maintenance therapy has been tested in patients with seborrheic dermatitis (SD). Objective We sought to compare the efficacy and tolerance of tacrolimus 0.1% ointment versus ciclopiroxolamine 1% cream as maintenance therapy for severe SD. Methods This double-blind randomized controlled study was conducted from 2014 to 2017 in 5 Dermatology Departments and 15 dermatology practices in France. Consecutive patients with severe and chronic facial SD were included. Patients were initially treated with desonide 0.05% cream twice daily for 7 days. Patients cleared after this open phase were randomized to receive tacrolimus 0.1% or ciclopiroxolamine 1% cream 2 times a week 24 weeks. The primary endpoint was disease-free-duration, defined as the time from randomization to first relapse. Results One hundred fourteen patients were randomized (tacrolimus, n = 57; ciclopiroxolamine, n = 57). Twelve patients relapsed in the tacrolimus group after a median delay of 91.5 days (range 15-195 days) versus 23 patients in the ciclopiroxolamine group (median delay, 27 days [range 13-201 days]). Comparison of disease-free duration curves showed that patients in the tacrolimus group had a longer duration of complete remission than those in the ciclopiroxolamine group (P = .018), corresponding to a hazard ratio of relapse of 0.44 (95% confidence interval 0.22-0.89; P = .022). Limitations The theoretical sample size was not reached. Conclusion Tacrolimus 0.1% is more effective than ciclopiroxolamine 1% as maintenance therapy for patients with facial SD." @default.
- W3090599855 created "2020-10-08" @default.
- W3090599855 creator A5002568287 @default.
- W3090599855 creator A5005282473 @default.
- W3090599855 creator A5006277322 @default.
- W3090599855 creator A5007874461 @default.
- W3090599855 creator A5009757671 @default.
- W3090599855 creator A5013920877 @default.
- W3090599855 creator A5017663076 @default.
- W3090599855 creator A5018660923 @default.
- W3090599855 creator A5021768529 @default.
- W3090599855 creator A5025877004 @default.
- W3090599855 creator A5027263425 @default.
- W3090599855 creator A5029781474 @default.
- W3090599855 creator A5030003424 @default.
- W3090599855 creator A5034932126 @default.
- W3090599855 creator A5040148300 @default.
- W3090599855 creator A5040511657 @default.
- W3090599855 creator A5048185906 @default.
- W3090599855 creator A5050985511 @default.
- W3090599855 creator A5052144370 @default.
- W3090599855 creator A5067321983 @default.
- W3090599855 creator A5067824307 @default.
- W3090599855 creator A5068055554 @default.
- W3090599855 creator A5069666561 @default.
- W3090599855 creator A5078564033 @default.
- W3090599855 date "2021-05-01" @default.
- W3090599855 modified "2023-10-01" @default.
- W3090599855 title "Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study" @default.
- W3090599855 cites W1893668115 @default.
- W3090599855 cites W1976742727 @default.
- W3090599855 cites W1977409771 @default.
- W3090599855 cites W1986466041 @default.
- W3090599855 cites W1994482649 @default.
- W3090599855 cites W1996579075 @default.
- W3090599855 cites W1999541518 @default.
- W3090599855 cites W2015166934 @default.
- W3090599855 cites W2026675401 @default.
- W3090599855 cites W2037537994 @default.
- W3090599855 cites W2041961159 @default.
- W3090599855 cites W2042035679 @default.
- W3090599855 cites W2044080834 @default.
- W3090599855 cites W2048490242 @default.
- W3090599855 cites W2049228926 @default.
- W3090599855 cites W2059471668 @default.
- W3090599855 cites W2060407666 @default.
- W3090599855 cites W2063916522 @default.
- W3090599855 cites W2070234752 @default.
- W3090599855 cites W2070624913 @default.
- W3090599855 cites W2071604012 @default.
- W3090599855 cites W2096991001 @default.
- W3090599855 cites W2124450032 @default.
- W3090599855 cites W2465777630 @default.
- W3090599855 cites W3012632332 @default.
- W3090599855 cites W4234328512 @default.
- W3090599855 cites W4376595371 @default.
- W3090599855 doi "https://doi.org/10.1016/j.jaad.2020.09.055" @default.
- W3090599855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33010323" @default.
- W3090599855 hasPublicationYear "2021" @default.
- W3090599855 type Work @default.
- W3090599855 sameAs 3090599855 @default.
- W3090599855 citedByCount "7" @default.
- W3090599855 countsByYear W30905998552020 @default.
- W3090599855 countsByYear W30905998552021 @default.
- W3090599855 countsByYear W30905998552022 @default.
- W3090599855 countsByYear W30905998552023 @default.
- W3090599855 crossrefType "journal-article" @default.
- W3090599855 hasAuthorship W3090599855A5002568287 @default.
- W3090599855 hasAuthorship W3090599855A5005282473 @default.
- W3090599855 hasAuthorship W3090599855A5006277322 @default.
- W3090599855 hasAuthorship W3090599855A5007874461 @default.
- W3090599855 hasAuthorship W3090599855A5009757671 @default.
- W3090599855 hasAuthorship W3090599855A5013920877 @default.
- W3090599855 hasAuthorship W3090599855A5017663076 @default.
- W3090599855 hasAuthorship W3090599855A5018660923 @default.
- W3090599855 hasAuthorship W3090599855A5021768529 @default.
- W3090599855 hasAuthorship W3090599855A5025877004 @default.
- W3090599855 hasAuthorship W3090599855A5027263425 @default.
- W3090599855 hasAuthorship W3090599855A5029781474 @default.
- W3090599855 hasAuthorship W3090599855A5030003424 @default.
- W3090599855 hasAuthorship W3090599855A5034932126 @default.
- W3090599855 hasAuthorship W3090599855A5040148300 @default.
- W3090599855 hasAuthorship W3090599855A5040511657 @default.
- W3090599855 hasAuthorship W3090599855A5048185906 @default.
- W3090599855 hasAuthorship W3090599855A5050985511 @default.
- W3090599855 hasAuthorship W3090599855A5052144370 @default.
- W3090599855 hasAuthorship W3090599855A5067321983 @default.
- W3090599855 hasAuthorship W3090599855A5067824307 @default.
- W3090599855 hasAuthorship W3090599855A5068055554 @default.
- W3090599855 hasAuthorship W3090599855A5069666561 @default.
- W3090599855 hasAuthorship W3090599855A5078564033 @default.
- W3090599855 hasConcept C141071460 @default.
- W3090599855 hasConcept C142724271 @default.
- W3090599855 hasConcept C16005928 @default.
- W3090599855 hasConcept C168563851 @default.
- W3090599855 hasConcept C204787440 @default.
- W3090599855 hasConcept C27081682 @default.
- W3090599855 hasConcept C2777484424 @default.